Business

Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM

Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce that it has submitted a renewal application to Servicio Nacional Forestal y de Fauna Silvestre ("SERFOR"). SERFOR a specialized Peruvian technical governmental agency under the Ministry of Agriculture, responsi

articleNeural Therapeutics Inc.May 9, 20254/company/neural-therapeutics-inc/news/neural-therapeutics-announces-serfor-permit-renewal-submission-and-extension-of-loi-with-hanfcom
Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM

About this update from Neural Therapeutics Inc.

[{"type":"text","content":"Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce that it has submitted a renewal application to Servicio Nacional Forestal y de Fauna Silvestre ("SERFOR"). SERFOR a specialized Peruvian technical governmental agency under the Ministry of Agriculture, responsible for regulating forest and wildlife matters, as well as proposing policies, strategies and plans to promote the sustainable use of forest and wildlife resources. Neural is also announcing the extension of its letter of intent ("LOI") with CWE European Holdings Inc. ("CWE"), doing business as "Hanf.com".","length":872,"tagName":"p"},{"type":"text","content":"SERFOR Permit Renewal Application","length":33,"tagName":"p"},{"type":"text","content":"As disclosed in Neural's Form 2A Listing Statement dated March 7, 2025, Neural and its Peruvian partners, Cactus Knize and Cayetano University completed the wild plant harvesting portion of the sampling program in Peru, under the auspices of Neural's SERFOR Authorization in late 2023 and early 2024. The harvested samples were delivered by Cactus Knize to Cayetano University's laboratory testing facilities, where a number of analyses were completed on the samples. Due to the highly specialized nature of the required analysis, which primarily focused on DNA identification of the collected species, some work and interpretation were outsourced to third-party experts by Cayetano University.","length":706,"tagName":"p"},{"type":"text","content":"Given the novelty of the DNA analysis methods employed and the limited scientific literature available on the DNA profiles of cacti in the Echninopsis genus[1], Neural has determined that further analysis is necessary to provide a reliable characterization of the collected cacti specimens.","length":290,"tagName":"p"},{"type":"text","content":"One of SERFOR's mandates is the enforcement of the Convention on International Trade in Endangered Species of Wild Fauna and Flora ("CITES"), which is a multilateral treaty aimed at protecting endangered plants and animals from the ...

More updates from Neural Therapeutics Inc.

Cayetano Universityletter of intentCactus Knizetherapeutic drugsFauna Silvestre